Eli Lilly to buy Versanis for up to $1.93bn in obesity drugs push
Eli Lilly and Co has announced that it will buy privately held Versanis for potentially up to $1.93bn to strengthen its position in the fast-growing
Eli Lilly and Co has announced that it will buy privately held Versanis for potentially up to $1.93bn to strengthen its position in the fast-growing